Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001140361-22-024842
Filing Date
2022-07-01
Accepted
2022-07-01 17:29:32
Documents
10

Document Format Files

Seq Description Document Type Size
1 PRER14A ny20004078x12_prer14a.htm PRER14A 6946436
2 logo_centerviewpartnersv2.jpg GRAPHIC 20936
3 logo_neogenx1.jpg GRAPHIC 26380
4 ny20004078x12-pc_1x1.jpg GRAPHIC 734333
5 ny20004078x12-pc_2x1.jpg GRAPHIC 689384
6 ny20004078x12_flowchartx1.jpg GRAPHIC 97606
7 ny20004078x12_flowchartx2.jpg GRAPHIC 99702
8 ny20004078x12_flowchartx3.jpg GRAPHIC 61577
9 ny20004078x12_piechart01.jpg GRAPHIC 64155
10 ny20004078x12_piechart02.jpg GRAPHIC 47573
  Complete submission text file 0001140361-22-024842.txt   9482048
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: PRER14A | Act: 34 | File No.: 000-17988 | Film No.: 221062487
SIC: 2835 In Vitro & In Vivo Diagnostic Substances